Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Technical Advisory Board Enhanced

9 Jan 2013 07:00

RNS Number : 1103V
Oxford Advanced Surfaces Group PLC
09 January 2013
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

Technical Advisory Board Enhanced

 

Oxford Advanced Surfaces Group ("OAS") the AIM listed technology developer targeting a number of global markets including consumer and industrial displays, solar panels, eyewear and the electronics and adhesion markets, has today announced a key addition to its Technical Advisory Board ("TAB").

 

From 1 January 2013, Professor Steven Abbott joined Professor Mark Moloney on the OAS TAB. Steven brings with him a wealth of industrial, scientific and commercial knowledge from both research posts and a long commercial career at ICI and MacDermid Autotype, covering all areas of the OAS target markets. He is a Fellow of the Royal Society of Chemistry and an independent consultant to global tier 1 industrial partners.

 

Adrian Meldrum, CEO said:

 

 "We are delighted to welcome Steven to the Advisory Board. He has many years of invaluable experience in the key industries and applications in which we operate and will add significant value to our technical and commercial discussions with prospective users of our technology."

 

Prof Steven Abbott commented:

 

 "I am very excited by the opportunity to work with OAS. Its technology offers a range of innovative solutions to significant problems in the world of manufacturing.."

 

 

Prof Steven Abbott received his Oxford Chemistry D Phil for work carried out at Harvard. His post-doctoral was in the Nobel Prizewinning lab of Jean-Marie Lehn at Strasbourg. He is Visiting Professor at the School of Engineering at the University of Leeds. He has worked many years in the high-tech coating industry and along the way developed a passion for computer models that could give real-world insight to complex scientific issues such as precision coating or polymer/nanoparticle solubilities. He is an independent consultant at Steven Abbott TCNF Ltd where he continues to develop software apps on solubility, surfactancy, adhesion, diffusion and advises internationally on topics as diverse as cosmetic/pharma skin delivery, organic photovoltaics, packaging films and "green" surfactant design.

 

09 January 2013

Enquiries:

 

Oxford Advances Surfaces Group Plc www.oxfordsurfaces.com

Adrian Meldrum, Chief Executive Officer

Philip Spinks, Chief Financial Officer T: 01865 854 807

 

W H Ireland Limited www.wh-ireland.co.uk

John Wakefield / Marc Davies T: 0117 945 3471

 

Lothbury FS Ltd www.lothburyfs.com

Gary Middleton / Michael Padley T: 0203 440 7620

 

 

Editors' Note

 

Oxford Advanced Surfaces Group plc (OAS) is a research-based company that develops and licenses intellectual property and products in the areas of highly reactive chemistry and anti-reflective coatings. The Company's research scientists develop innovative solutions in advanced materials and nano-technology for partners to exploit. The Company's solutions apply to real-world, practical processing and innovation challenges as novel polymer and organic materials are introduced to improve cost, weight, space and performance in new products. Initial applications include advanced adhesion, anti-reflective coatings and particle delivery in markets including conventional and plastic electronics, optics, displays, batteries and solar.

www.oxfordsurfaces.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKFDKOBKDDDK
Date   Source Headline
28th Aug 20209:05 amRNSSecond Price Monitoring Extn
28th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20208:54 amRNSHolding(s) in Company
11th Aug 20204:13 pmRNSHolding(s) in Company
6th Aug 202012:30 pmRNSHolding(s) in Company
29th Jul 202012:16 pmRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
23rd Jul 20209:59 amRNSHolding(s) in Company
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20205:11 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSResults of Placing
13th Jul 20207:00 amRNSPlacing and Subscription to raise £2.1 million
2nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20201:39 pmRNSResult of AGM and Directorate Change
4th Jun 20207:00 amRNSDigitalGlassware to Interface with Waters’ UNIFI
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSFinal Results
26th May 20207:00 amRNSNotice of Results and Investor Presentation
11th May 202011:57 amRNSHolding(s) in Company
1st May 20208:21 amRNSHolding(s) in Company
28th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSContract with Cancer Research UK Beatson Institute
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
12th Feb 20207:00 amRNSDeepMatter collaborates with University of Leeds
24th Jan 20207:00 amRNSChange of Adviser
21st Jan 20206:10 pmRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDeepMatter Appoints Industry Advisors
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 201911:05 amRNSSecond Price Monitoring Extn
9th Dec 201911:00 amRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSDeepMatter collaboration with AstraZeneca
19th Sep 20197:00 amRNSInterim Results
12th Aug 20197:00 amRNSLaunch of DigitalGlassware Online Portal
8th Aug 20197:00 amRNSFirst revenues for DigitalGlassware
3rd Jul 20192:55 pmRNSChange of Registered Address
28th Jun 20197:00 amRNSDirectorate Change
21st Jun 201912:34 pmRNSChange of Adviser
3rd Jun 20193:41 pmRNSHolding(s) in Company
22nd May 201911:19 amRNSResult of AGM
12th Apr 20197:01 amRNSBoard Changes & Appointments to Advisory Committee
12th Apr 20197:00 amRNSFinal Results
11th Apr 20195:12 pmRNSHolding(s) in Company
10th Apr 201912:58 pmRNSHolding(s) in Company
4th Apr 20193:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.